Burgdorf - Ypsomed has resumed production of the dialling unit for the OptiClik pen system as planned following an intensive optimisation phase. Matthew Robin, CEO of Ypsomed, explains: "The adjustments in the production have been successfully implemented, enabling Ypsomed to resume deliveries of newly produced OptiClik pen systems to sanofi-aventis. We have also increased OptiSet production at both the Burgdorf and Solothurn sites to 24 hours seven days a week." Production of the OptiClik dialling unit had to be suspended for a total of eight weeks in order to carry out the technical adjustments to the manufacturing process.
Press Releases Ypsomed Group